{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042172","form_type":"8-K","ticker":"LIXT","cik":"0001335105","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2024-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.207212+00:00","generated_at":"2026-05-30T11:00:47.307212+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lixte Biotechnology gets Nasdaq extension to Feb 18, 2025 to meet equity requirement","bullets":["Nasdaq notified non-compliance with $2.5M minimum stockholders' equity requirement.","Company submitted compliance plan; Nasdaq granted extension until February 18, 2025.","Filed S-1 registration statement to raise up to $4.0M in equity capital.","Failure to evidence compliance by March 31, 2025 may lead to delisting.","Common stock and warrants continue trading on Nasdaq under LIXT and LIXTW."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042172","json":"https://secwatch.observer/filing/0001493152-24-042172.json","markdown":"https://secwatch.observer/filing/0001493152-24-042172.md","text":"https://secwatch.observer/filing/0001493152-24-042172.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000149315224042172/0001493152-24-042172-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000149315224042172/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T11:00:47.307212+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}